Inhibition of SW620 human colon cancer cells by upregulating miRNA-145
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of SW620 human colon cancer cells by upregulating miRNA-145
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 9, Pages 2771
Publisher
Baishideng Publishing Group Inc.
Online
2016-03-02
DOI
10.3748/wjg.v22.i9.2771
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer
- (2014) Anna Panza et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Predictors of recurrence free survival for patients with stage II and III colon cancer
- (2014) Vassiliki L Tsikitis et al. BMC CANCER
- The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life
- (2014) Renate M Winkels et al. BMC CANCER
- An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration
- (2014) Raghu R. Chivukula et al. CELL
- Targeted therapy in metastatic colon cancer
- (2014) Vijaya R Bhatt Future Oncology
- MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC)
- (2014) Xianchun Duan et al. GENE
- A mechanically-induced colon cancer cell population shows increased metastatic potential
- (2014) Xin Tang et al. Molecular Cancer
- MicroRNA-223 functions as an oncogene in human colorectal cancer cells
- (2014) JUFENG ZHANG et al. ONCOLOGY REPORTS
- MicroRNA-21 as a potential colon and rectal cancer biomarker
- (2014) Tao Li WORLD JOURNAL OF GASTROENTEROLOGY
- Hallmarks in colorectal cancer: Angiogenesis and cancer stem-like cells
- (2014) Muriel Mathonnet WORLD JOURNAL OF GASTROENTEROLOGY
- Review The diagnostics of colorectal cancer
- (2014) Magdalena Świderska et al. Wspolczesna Onkologia-Contemporary Oncology
- Mechanisms of buffer therapy resistance
- (2014) Kate M. Bailey et al. NEOPLASIA
- Modulators affecting the immune dialogue between human immune and colon cancer cells
- (2014) Meir Djaldetti World Journal of Gastrointestinal Oncology
- DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells
- (2013) Akio Iio et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- RNA Interference in the Treatment of Colon Cancer
- (2013) Jose Prados et al. BIODRUGS
- Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1
- (2012) Yu Yin et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells
- (2012) Lea H Gregersen et al. BMC CANCER
- Development of microRNA-145 for therapeutic application in breast cancer
- (2011) Seok-Jun Kim et al. JOURNAL OF CONTROLLED RELEASE
- Lentivirus-mediated siRNA interference targeting SGO-1 inhibits human NSCLC cell growth
- (2011) Lili Liu et al. TUMOR BIOLOGY
- MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
- (2009) H-C Chen et al. BRITISH JOURNAL OF CANCER
- MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
- (2009) M. Sachdeva et al. CANCER RESEARCH
- Identification of novel microRNA targets based on microRNA signatures in bladder cancer
- (2009) Takahiro Ichimi et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
- (2008) T. Schepeler et al. CANCER RESEARCH
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
- (2008) Qihong Huang et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started